BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

826 related articles for article (PubMed ID: 30596875)

  • 1. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.
    Wolff RF; Moons KGM; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S;
    Ann Intern Med; 2019 Jan; 170(1):51-58. PubMed ID: 30596875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Introduction of the Prediction model Risk Of Bias ASsessment Tool: a tool to assess risk of bias and applicability of prediction model studies].
    Chen R; Wang SF; Zhou JC; Sun F; Wei WW; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):776-781. PubMed ID: 32447924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.
    Moons KGM; Wolff RF; Riley RD; Whiting PF; Westwood M; Collins GS; Reitsma JB; Kleijnen J; Mallett S
    Ann Intern Med; 2019 Jan; 170(1):W1-W33. PubMed ID: 30596876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence.
    Collins GS; Dhiman P; Andaur Navarro CL; Ma J; Hooft L; Reitsma JB; Logullo P; Beam AL; Peng L; Van Calster B; van Smeden M; Riley RD; Moons KG
    BMJ Open; 2021 Jul; 11(7):e048008. PubMed ID: 34244270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
    Venema E; Wessler BS; Paulus JK; Salah R; Raman G; Leung LY; Koethe BC; Nelson J; Park JG; van Klaveren D; Steyerberg EW; Kent DM
    J Clin Epidemiol; 2021 Oct; 138():32-39. PubMed ID: 34175377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraising prediction research: a guide and meta-review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST).
    de Jong Y; Ramspek CL; Zoccali C; Jager KJ; Dekker FW; van Diepen M
    Nephrology (Carlton); 2021 Dec; 26(12):939-947. PubMed ID: 34138495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training.
    Kaiser I; Pfahlberg AB; Mathes S; Uter W; Diehl K; Steeb T; Heppt MV; Gefeller O
    J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies.
    Tomlinson E; Cooper C; Davenport C; Rutjes AWS; Leeflang M; Mallett S; Whiting P
    J Clin Epidemiol; 2024 Apr; 171():111370. PubMed ID: 38670243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST.
    Wang S; Huang H; Hou M; Xu Q; Qian W; Tang Y; Li X; Qian G; Ma J; Zheng Y; Shen Y; Lv H
    Pediatr Res; 2023 Sep; 94(3):1125-1135. PubMed ID: 36964445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement.
    Langenhuijsen LFS; Janse RJ; Venema E; Kent DM; van Diepen M; Dekker FW; Steyerberg EW; de Jong Y
    J Clin Epidemiol; 2023 Jul; 159():159-173. PubMed ID: 37142166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.
    Wynants L; Van Calster B; Collins GS; Riley RD; Heinze G; Schuit E; Bonten MMJ; Dahly DL; Damen JAA; Debray TPA; de Jong VMT; De Vos M; Dhiman P; Haller MC; Harhay MO; Henckaerts L; Heus P; Kammer M; Kreuzberger N; Lohmann A; Luijken K; Ma J; Martin GP; McLernon DJ; Andaur Navarro CL; Reitsma JB; Sergeant JC; Shi C; Skoetz N; Smits LJM; Snell KIE; Sperrin M; Spijker R; Steyerberg EW; Takada T; Tzoulaki I; van Kuijk SMJ; van Bussel B; van der Horst ICC; van Royen FS; Verbakel JY; Wallisch C; Wilkinson J; Wolff R; Hooft L; Moons KGM; van Smeden M
    BMJ; 2020 Apr; 369():m1328. PubMed ID: 32265220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool).
    Lunny C; Veroniki AA; Hutton B; White I; Higgins J; Wright JM; Kim JY; Thirugnanasampanthar SS; Siddiqui S; Watt J; Moja L; Taske N; Lorenz RC; Gerrish S; Straus S; Minogue V; Hu F; Lin K; Kapani A; Nagi S; Chen L; Akbar-Nejad M; Tricco AC
    BMJ Evid Based Med; 2023 Feb; 28(1):58-67. PubMed ID: 35948412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.
    Kaiser I; Mathes S; Pfahlberg AB; Uter W; Berking C; Heppt MV; Steeb T; Diehl K; Gefeller O
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models.
    Fernandez-Felix BM; López-Alcalde J; Roqué M; Muriel A; Zamora J
    BMC Med Res Methodol; 2023 Feb; 23(1):44. PubMed ID: 36800933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining Bias and Reporting in Oral Health Prediction Modeling Studies.
    Du M; Haag D; Song Y; Lynch J; Mittinty M
    J Dent Res; 2020 Apr; 99(4):374-387. PubMed ID: 32028825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Risk of Bias in Neuroimaging-Based Artificial Intelligence Models for Psychiatric Diagnosis: A Systematic Review.
    Chen Z; Liu X; Yang Q; Wang YJ; Miao K; Gong Z; Yu Y; Leonov A; Liu C; Feng Z; Chuan-Peng H
    JAMA Netw Open; 2023 Mar; 6(3):e231671. PubMed ID: 36877519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study.
    Di J; Li X; Yang J; Li L; Yu X
    Risk Manag Healthc Policy; 2022; 15():1189-1201. PubMed ID: 35702399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for a systematic review on the methodological and reporting quality of prediction model studies using machine learning techniques.
    Andaur Navarro CL; Damen JAAG; Takada T; Nijman SWJ; Dhiman P; Ma J; Collins GS; Bajpai R; Riley RD; Moons KG; Hooft L
    BMJ Open; 2020 Nov; 10(11):e038832. PubMed ID: 33177137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.